arrow
M

Madhvi Rajpurkar

Cornell University
H指数:23
被引数:2,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

“A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease”: comment

“一项开放标签的1期研究,旨在评估单次静脉注射efanesoctocog alfa在2N型或3型血管性血友病患者中的药代动力学、安全性和耐受性”:评论

2026-05-040
PRE
Relationship of sociodemographic factors to presentation and natural history of provoked venous thromboembolism in u.s. children: A secondary analysis of the multinational kids-DOTT trial

社会人口因素与诱导性静脉血栓栓塞在美国儿童中的临床表现和自然病程的关系:一项跨国kids-DOTT试验的二次分析

Blood
IF23.1
2025-12-010
PRE
Clinically Relevant Outcomes for Research in Pediatric Pulmonary Embolism: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Haemostasis

儿科肺栓塞研究的临床相关结局:ISTH SSC儿科/新生儿血栓与止血学组委员会的通讯

2025-11-030
PRE
The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism

静脉血栓栓塞性疾病 (FUVID) 研究的功能特征: 前瞻性,观察性,多中心研究的原理,设计和方法,以评估小儿肺栓塞后运动不耐受和呼吸困难的机制

2024-12-010
OAAI
Illustrated State-of-the-Art Capsules of the ISTH 2021 Congress
2021-07-011
OAAI
ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genes

ETV6种系突变导致HDAC3/NCOR2错误定位和干扰素应答基因上调

2020-09-1721
OA